Aller au contenu

Phase IB part of LOC-R01, a LOC network non-comparative randomized phase IB/II study testing R-MPV in combination with escalating doses of lenalidomide or ibrutinib for newly diagnosed primary central nervous system lymphoma (PCNSL) patients.

Nom du journal : J Hematol Oncol

Année : 2024

Volume : 17

Page de départ : 86

Auteurs: Alcantara, M, Chevrier, M, Jardin, F, Schmitt, A, Houillier, C, Oberic, L & al,